These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10217308)

  • 1. A new insulin-mimetic vanadyl complex, (N-pyridylmethylaspartate)oxovanadium(IV) with VO(N2O2) coordination mode, and evaluation of its effect on uptake of D-glucose by Ehrlich ascites tumour cells.
    Tawa R; Uchida K; Taniyama J; Fujisawa Y; Fujimoto S; Nagaoka T; Kanamori K; Sakurai H
    J Pharm Pharmacol; 1999 Feb; 51(2):119-24. PubMed ID: 10217308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
    Yasui H; Tamura A; Takino T; Sakurai H
    J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats.
    Sakurai H; Sano H; Takino T; Yasui H
    J Inorg Biochem; 2000 May; 80(1-2):99-105. PubMed ID: 10885469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
    Takino T; Yasui H; Yoshitake A; Hamajima Y; Matsushita R; Takada J; Sakurai H
    J Biol Inorg Chem; 2001 Feb; 6(2):133-42. PubMed ID: 11293406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes.
    Adachi Y; Sakurai H
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):428-33. PubMed ID: 15056957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
    Sakurai H; Fujii K; Watanabe H; Tamura H
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
    Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
    J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro study of the insulin-like action of vanadyl-pyrone and -pyridinone complexes with a VO(O4) coordination mode.
    Rangel M; Tamura A; Fukushima C; Sakurai H
    J Biol Inorg Chem; 2001 Feb; 6(2):128-32. PubMed ID: 11293405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
    Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y
    J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
    J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo coordination structural changes of a potent insulin-mimetic agent, bis(picolinato)oxovanadium(IV), studied by electron spin-echo envelope modulation spectroscopy.
    Fukui K; Fujisawa Y; OhyaNishiguchi H; Kamada H; Sakurai H
    J Inorg Biochem; 1999; 77(3-4):215-24. PubMed ID: 10643660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study on gastrointestinal absorption of insulinomimetic vanadyl complexes in rats by ESR spectroscopy.
    Fugono J; Yasui H; Sakurai H
    J Pharm Pharmacol; 2001 Sep; 53(9):1247-55. PubMed ID: 11578107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanadyl-biguanide complexes as potential synergistic insulin mimics.
    Woo LC; Yuen VG; Thompson KH; McNeill JH; Orvig C
    J Inorg Biochem; 1999 Sep; 76(3-4):251-7. PubMed ID: 10605840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of insulin signaling pathway in adipocytes by oxovanadium(IV) complexes.
    Basuki W; Hiromura M; Adachi Y; Tayama K; Hattori M; Sakurai H
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1163-70. PubMed ID: 16970914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
    Nakai M; Watanabe H; Fujiwara C; Kakegawa H; Satoh T; Takada J; Matsushita R; Sakurai H
    Biol Pharm Bull; 1995 May; 18(5):719-25. PubMed ID: 7492989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.
    Takeshita S; Kawamura I; Yasuno T; Kimura C; Yamamoto T; Seki J; Tamura A; Sakurai H; Goto T
    J Inorg Biochem; 2001 Jun; 85(2-3):179-86. PubMed ID: 11410238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
    Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
    Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative assessment of cell mechanisms of the antidiabetic action of a new organic derivative of oxovanadium(IV) and vanadyl sulfate].
    Aleeva GN; Kiiasov AP; Burykin IM; Khafiz'ianova RKh
    Eksp Klin Farmakol; 2004; 67(3):42-4. PubMed ID: 15341067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid.
    Nakai M; Obata M; Sekiguchi F; Kato M; Shiro M; Ichimura A; Kinoshita I; Mikuriya M; Inohara T; Kawabe K; Sakurai H; Orvig C; Yano S
    J Inorg Biochem; 2004 Jan; 98(1):105-12. PubMed ID: 14659639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.